The EUPESMA Survey revealed that only 30.7% could choose which SMA medicine to start, while 89.6% consider stabilisation to be meaningful progress.

Treatment decisions should reflect the priorities of people living with SMA.

🔗https://heyzine.com/flip-book/f9722b6437.html

#EUPESMA #SMAEurope